Co-reporter:Weichang Li, Junpei Kang, Yulin Yuan, Fengcai Xiao, Hang Yao, Sa Liu, Jianxi Lu, Yingjun Wang, Zhen Wang, Li Ren
Composites Science and Technology 2016 Volume 128() pp:58-64
Publication Date(Web):18 May 2016
DOI:10.1016/j.compscitech.2016.03.013
The poly(vinyl alcohol) (PVA) hydrogel is regarded as a potential articular cartilage replacement for its good biocompatibility, high permeability to fluid and load-bearing properties. This work investigated a novel Poly(vinyl alcohol)-polyetheretherketone/Poly(vinyl alcohol)-β-tricalcium phosphate (PVA-PEEK/PVA-β-TCP) bilayered hydrogels by freezing-thawing with biomimetic properties for articular cartilage and subchondral bone is developed. The bilayered hydrogels microarchitecture consists of a highly porous and dense structure, and the internal structure were analyzed by micro-CT. The morphology of the resulting hydrogels was analyzed by scanning electron microscopy (SEM), the enhancement of the mechanical properties of the PVA-PEEK/PVA-β-TCP bilayered hydrogels were demonstrated by mechanical testing. The bilayered structure indicate that a good bonding exist between the two layers, which is known to be a requisite necessary to assure a good integrity and functionality of the osteochondral construct. In addition, in vitro cell culture studies revealed that the hydrogels has no negative effect on the cell viability and proliferation and possess good biocompatibility. Then, the bilayered hydrogels were implanted into the knee joint defect of rabbits and hematoxylin and eosin and immunohistochemical staining. The PVA-PEEK/PVA-β-TCP bilayered hydrogels show good potential for use in the field of articular cartilage repair.
Co-reporter:Zhen Wang;Wei Wang;Xin Xiao
Pediatric Drugs 2014 Volume 16( Issue 6) pp:503-512
Publication Date(Web):2014/12/01
DOI:10.1007/s40272-014-0095-z
Despite a large number of publications on outcomes of second-line chemotherapy for osteosarcoma, there is little consensus on efficacy of the therapy.Our objective was to systematically categorize published evidence for chemotherapy for metastatic, relapsed and refractory osteosarcoma in order to provide an updated and comprehensive analysis of the clinical outcomes.We performed a search of PubMed and EMBASE to identify published articles reporting on validated clinical outcomes measures (the rate of complete response [CR] and partial response [PR], the rate of stable disease [SD] and progressive disease [PD] and the 5-year overall survival) after chemotherapy in patients with metastatic, relapsed and refractory osteosarcoma. A total of 20 articles were identified and stratified by different regimens. Finally, six regimens that have at least two drugs were reviewed. Weighted averages of each outcome were computed.The weighted average overall response rate (CR + PR) for the combination of ifosfamide, etoposide and high-dose methotrexate therapy was 62 %, and the tumor control rate (CR + PR + SD) was 92.3 %; the highest of all six regimens. The weighted average overall response rate and tumor control rate of ifosfamide–etoposide therapy (41.7 and 77.9 %, respectively) were the highest of the two-drug regimens. Weighted average overall response rate and tumor control rate for the remaining regimens were 20.5 and 56.8 %, respectively, for cyclophosphamide-etoposide; 30.0 and 73.5 % for ifosfamide, carboplatin, and etoposide; 12.0 and 40.0 % for cyclophosphamide–topotecan; and 14.5 and 36.4 % for gemcitabine–docetaxel.A chemotherapy regimen comprising both a cell cycle-specific drug and a cell cycle-nonspecific drug could increase response rates. The combination of ifosfamide and etoposide therapy is our first choice in two-drug regimens. Regarding three-drug regimens, adding a cell cycle-specific drug to ifosfamide–etoposide therapy may result in a better response rate than adding a cell cycle-nonspecific drug, or any other two-drug regimens in current studies. Hence, we recommend the use of second-line chemotherapy based on the combination ifosfamide–etoposide regimen in patients with metastatic, relapsed and refractory osteosarcoma.
Co-reporter:Kaili Lin;Wei Yuan;Lu Wang;Jianxi Lu;Lei Chen;Jiang Chang
Journal of Biomedical Materials Research Part B: Applied Biomaterials 2011 Volume 99B( Issue 2) pp:350-358
Publication Date(Web):
DOI:10.1002/jbm.b.31906
Abstract
Implantation of synthetic materials into body elicits inflammatory host responses that limit medical device integration and biological performance. Since the effective use of biomaterials in vivo requires good biocompatibility and bio-functionality, it is vital that we assess the inflammatory reactions provoked by various implanted biomaterials. In chemical precipitation of β-tricalcium phosphate [β-Ca3(PO4)2, β-TCP], the impurity of calcium pyrophosphate (Ca2P2O7, CPP) will easily appear if the preparation conditions are not well controlled. To test the influences of CCP-impurity on the biocompatibility of the material, four groups of β-TCP ceramic samples doped with 0.5–10 wt % of CCP impurity, and pure β-TCP and CCP samples were fabricated and implanted in rat subcutaneous site for one, two, and four weeks. The host tissue responses to the ceramics were evaluated by histomorphometric analysis, and the results were compared with pure β-TCPbioceramics. The results show that the CPP impurity can elicit and stimulate the inflammatory responses at the tissue/implant interface. Moreover, with the increase of CPP doping amount, the inflammation increases apparently. However, the pure β-TCP bioceramics only present slight post-implantation inflammatory responses. The influence of the CPP doping on the inflammatory responses is mainly related to a microparticles release because of an insufficient sintering of β-TCP by CPP doping. The microparticle release could be at the origin of local inflammation and cell/tissue damages. Therefore, to obtain perfect biocompatibility and high quality β-TCP bioceramics, it is important to avoid and control the CPP impurity in the preparation of β-TCP powders and bioceramics. © 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2011.
Co-reporter:Zhen Wang;Bin Lu;Lei Chen;Jiang Chang
Journal of Materials Science: Materials in Medicine 2011 Volume 22( Issue 1) pp:185-191
Publication Date(Web):2011 January
DOI:10.1007/s10856-010-4175-5
The objective of this study is to evaluate local response to a bioactive glass based composite putty (NovaBone Putty) in a vertebral body defect model in sheep, as compared to NovaBone, a bioactive glass particulate. Two time periods were used for the study, 6 and 12 weeks. Empty defects were also used as a control. In comparing the three test groups, the relative amount of new bone for both grafted defects was substantially greater than for the empty controls (P < 0.05). At 6 weeks, the bone formation was 42% for NovaBone Putty, 27% for NovaBone and 1.2% for the ungrafted empty defect. At 12 weeks, the bone formation was 51.4% for NovaBone Putty, 47.3% for NovaBone and 5.1% for the empty defect. NovaBone Putty, the test material, had greater bone content than the NovaBone, both of which were significantly greater than the empty control.
Co-reporter:Chaofeng Wang;Aimin Li;Feng Bai;Jianxi Lu;Shanglong Xu;Dichen Li
Journal of Biomedical Materials Research Part A 2010 Volume 92A( Issue 3) pp:1145-1153
Publication Date(Web):
DOI:10.1002/jbm.a.32347
Abstract
Segmental bone defect resulted from trauma or excision of bone tumor or pathology represents a common and significant clinical problem. In an attempt to solve this dilemma, we use β-TCP combined with autologous bone marrow mesenchymal stem cells (auto-BMSC) and cultured by dynamic perfusion to repair the segmental bone defects of goat's tibia. The β-TCP scaffolds combined with auto-BMSC by dynamic perfusion bioreactor or in static state were respectively transplanted into the defect (30 mm) of the goat tibias. The X-ray films were gathered and analyzed at the different time points. At 24 weeks post-operation, tissue engineering bones implanted were analyzed by histology and Micro-CT. Results show that the capacity of osteogenesis in experimental group was higher than that of control group by X-ray, histological, and micro-CT analysis (p < 0.05). According to the study, we found that repair for segmental bone defects of tissue engineering bone cultured by dynamic perfusion culture bioreactor outweigh those cultured in static state. And we can conclude that this technology of tissue engineering bone will become a clinical method to the segmental bone-defects repair in the future. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res, 2010
Co-reporter:Lin Wang;Yun-Yu Hu;Xiang Li;Di-Chen Li;Bing-Heng Lu;Song-Feng Xu
Journal of Biomedical Materials Research Part A 2009 Volume 91A( Issue 1) pp:102-113
Publication Date(Web):
DOI:10.1002/jbm.a.32189
Abstract
One unsolved problem in bone tissue engineering is how to enable the survival and proliferation of osteoblastic cells in large scaffolds. In this work, large β-tricalcium phosphate scaffolds with tightly controlled channel architectures were fabricated and a custom-designed perfusion bioreactor was developed. Human fetal bone cells in third passage were seeded onto the scaffolds and cultured in static or flow perfusion conditions for up to 16 days. Compared with nonperfused constructs, flow perfused constructs demonstrated improved cells proliferation and differentiation according to cell viability, glucose consumption, alkaline phosphatase activity, and osteopontin. Moreover, after 16 days of perfusion culture, a homogenous layer composed of cells and mineralized matrix throughout the whole scaffold was observed by scanning electron microscopy and histological study. In contrast, cells were located only along the scaffold perimeter in static culture. These results demonstrated the feasibility and benefit of perfusion culture in conjunction with well-defined three-dimensional environment for large bone graft construction. Porous scaffold with controlled architecture can be a potential tool to evaluate the effects of scaffold specific geometry on fluid flow configuration and cell behavior under perfusion culture. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009
Co-reporter:Zhen Wang;Zheng Guo;Xiangdong Li
The Chinese-German Journal of Clinical Oncology 2009 Volume 8( Issue 11) pp:
Publication Date(Web):2009 November
DOI:10.1007/s10330-009-0129-0
The aim of the study was to analyze the clinical features of limb salvage surgery with epiphyseal preservation in children and adolescents, and to evaluate the recurrence rate, metastasis, complications, and the joint functional results after tumor resection.Between December 1995 and January 2003, 33 cases of preserving epiphysis procedure had been done. In this group, the tumor located in distal femur in 24 cases and in proximal tibia in 9 cases. There were 23 osteosarcomas, 6 Ewing’s sarcomas, 2 chondrosarcomas, and 2 aggressive osteoblastomas. The patients received 2–4 cycles of preoperative adjuvant chemotherapy, and another 6 cycles after surgery. The modified protocol T10 was taken. Radiography and MRI were used to determine the margins of the tumors preoperatively and histological examination was used to corroborate the evidence intraoperatively. The tumors were staged clinically. Among them, there were 2 cases in IA, 2 cases in IB, 17 cases in IIA, and 12 cases in IIB. According to the MRI analysis, the metaphyseal tumors in children were classified into 3 types. Type I, with the tumor close to but not contacting epiphyseal plate, and the distance between the two over 2 cm, was taken as absolute indication for the technique. Type II, with the tumor near or contacting epiphysis plate, and the distance between the two less than 1 cm, was taken as relative indication for the surgery. For type III, the tumor contacted the epiphyseal plate partially, and was over 2 cm beyond the joint. In the cohort, 18 cases were categorized as type I, 13 as type II, and 2 as type III. The size of the residual epiphyseal bone segment differed after different excision protocols which were taken according to the clinical classifications. Bone defects after tumor resections were repaired with massive intercalary allograft bone, followed by internal fixation by intramedullary nails and cancellous screws.Among the 33 cases, 3 cases were lost to follow up. 29 cases had complete clinical data. Postoperative follow-up was 12–72 months. Recurrences were seen in 3 cases, with one local recurrence in type III cases one year post tumor resection, other 2 recurrences around the femoral vessels in type II cases 15 months and 30 months after the tumor resection respectively. The recurrence rate accounted for 10.34%. Amputation was performed for the cases with recurrences. But pulmonary metastasis developed and the patients died. In this cohort, 9 cases died. Five-year survival rate constituted 57.94% demonstrated by Kaplan-Meier survival analysis. The median survival time for male patients was 64.36 months, and that for female patients was 56.00 months (P = 0.0403). The sites, stages and types were not associated with the survival time. Four cases reported 5 complications (17.24%). The complications included fracture of the allograft, limb length discrepancy, nerve injury, breakage of nails, and loosening of the screws. No patient reported skin necrosis, hematoma, infection, rejection to the allograft, and nonunion at the end of the follow-up. According to the functional evaluation criteria after surgical treatment of malignant tumors of the extremities introduced by Enneking, excellent functional results were reported in 11 cases, good in 13 cases, fair in 3 cases, and poor in 2 cases. The excellent or good result rate was 83%. The excision interface involved partial epiphysis in 4 cases, involved the epiphyseal plate in 8 cases. Intact epiphysis was preserved in 17 cases. Five cases with poor postoperative functional results were in types II and III. Average time of bone union was 2.5 months for epiphyseal end and 3.8 months for diaphyseal end. According to the International Society of Limb Salvage (ISOLS) radiological implants evaluation system, excellent reconstruction was observed in 23 cases, good reconstruction in 4 cases, fair reconstruction in 1 case, and poor reconstruction in 1 case. All patients in the group had satisfactory joint stability. No patient reported joint dislocation, valgus or varus deformity, and osteoarthritis. The average limb length discrepancy was 3.2 cm, ranging 2–6 cm.The limb salvage surgery with preservation of epiphysis for malignant bone tumors in children and adolescents guarantees the patient’s satisfactory postoperative limb functional results. Preoperative effective adjuvant chemotherapy and prevention of postoperative complications deserve great attention.